Cell Therapy for Immunomodulation in Kidney Transplantation

NCT03867617 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

OTHER: Regulatory T cells
DRUG: Tocilizumab
OTHER: Bone marrow
PROCEDURE: Kidney transplant
OTHER: Immunosuppressive drug therapy

Sponsor

Thomas Wekerle

Collaborators

[object Object]